Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique
- 1 October 1986
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 64 (2), 271-275
- https://doi.org/10.1111/j.1365-2141.1986.tb04119.x
Abstract
A new technique is described in which plasma cells actively synthesizing DNA can be identified in a heterogeneous cell population such as bone marrow. This method uses bromodeoxyuridine (BrdU) and a fluorescent monoclonal antibody against BrdU in combination with cytoplasmic staining for immunoglobulin (Ig). In 26 patients with monoclonal gammopathy (MG) the plasma cell labelling index (LI) as determined by this immunofluorescent method was compared with the tritited thymidine (3H-TdR) LI. No difference in sensitivity was found between the two methods. As the determination of the plasma cell LI with the BrdU/anti BrdU method is easy to perform and results can be obtained within 4 h, this immunofluorescent method seems to be an attractive alternative to the laborious time-consuming classic 3H-TdR LI.This publication has 7 references indexed in Scilit:
- Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.Proceedings of the National Academy of Sciences, 1983
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982
- Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidineBlood, 1981
- DRUG-RESISTANCE IN MULTIPLE-MYELOMA ASSOCIATED WITH HIGH INVITRO INCORPORATION OF THYMIDINE-H-31981
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980
- PRETREATMENT TUMOR MASS, CELL-KINETICS, AND PROGNOSIS IN MULTIPLE-MYELOMA1980
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975